In a study published in Cell, a research team led by Zhu Shujia from the Center for Excellence in Brain Science and ...

Research reveals that δ-receptor agonists like KNT-127 alleviate IBS symptoms by modulating gut-brain interactions and ...

A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can ...

Researchers have identified how CBD interacts with cannabinoid receptors to mitigate the negative effects of THC, the psychoactive component of cannabis.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Scientists have pinpointed a brain circuit that, when activated, reduces anxiety without impairing memory. Using ...

Researchers at CU Anschutz are studying the effect of psychedelic mushrooms on patients with treatment-resistant depression.

Irritable bowel syndrome (IBS) is a common digestive disorder with unclear causes, affecting about 10% of the global population. Researchers have now discovered that opioid delta-receptor agonists may ...

Early dysfunction of the endothelial/blood-brain barrier (BBB) is involved in the pathogenesis of cerebral small vessel disease (SVD), which is a contributor to about 50% of dementias.

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

New research found that individuals with anorexia nervosa have elevated opioid neurotransmitter activity, which may ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.